Benzylamine-related compounds stimulate rat vas deferens neurotransmission and potentiate memory in the mouse acting as potassium channel blockers

Pharmacological Research

Volumn 41, Issue 2, 2000, Pages 151-162

  Banchelli, G ^a   Raimondi, L ^a   Ghelardini, C ^a   Pirisino, R ^a   Bertini, V ^b   De Munno, A ^c   Lucchesini, F ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Amnestic effects; Benzylamine; Potassium channel blockers; Voltage operated calcium channels (VOCC)

Indexed keywords

2,6 DIBUTYLBENZYLAMINE; 2,6 DOPROPOXYBENZYLAMINE; 4 AMINOPYRIDINE; APAMIN; BARIUM CHLORIDE; BENZYLAMINE; BENZYLAMINE DERIVATIVE; BENZYLDIMETHYLAMINE; CALCIUM CHANNEL; CHARIBDOTOXIN; CROMAKALIM; GLIBENCLAMIDE; MINOXIDIL; OMEGA CONOTOXIN GVIA; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHLORIDE; TETRYLAMMONIUM; TOXIN; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; MALE; MEMORY; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; VAS DEFERENS;

EID: 0033839630     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1999.0571     Document Type: Article

References (27)

1. Selective inhibitors of benzylamine oxidases with respect to other amine oxidases
2. Calcium modulatory properties of 2,6-dibutylbenzilamine (B25) in rat isolated vas deferens, cardiac and smooth muscle preparations
3. The adrenergic innervation of the vas deferens and accessory male genital glands
4. Suramin: A selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens
5. Potassium channel modulators: Applications and therapeutic promise
6. The pharmacology of potassium channels and their therapeutic potential
7. Biphasic effect of KCl and other potassium channel blockers on rat vas deferens neurotransmission
8. A group of potassium-channel blockers - Acetylcholine releasers: New potentials for Alzheimer disease? A review
9. An improved one-trial passive avoidance learning situation
10. Influence of potassium channel modulators on cognitive processes in mice
11. A comparison of the antinociceptive responses to GABA-receptor agonists THIP and baclofen
12. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse
13. The effects of adrenoceptor agonists and antagonists on responses of transmurally stimulated prostatic and epididymal portions of the isolated vas deferens of the rat
14. Evidence to support the hypothesis that ATP is a co-transmitter in the rat vas deferens
15. P2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens
16. Differential effects of pinacidil and cromakalim on vascular relaxation and sympathetic neurotransmission
17. + channel blocking agents may augment sympathetic transmitter secretion by action 'upstream' of varicosities
18. 2 and 4-aminopyridine-evoked phasic contractions in the rat vas deferens
19. Cromakalim blocks the purinergic response evoked in rat vas deferens by single-pulse electrical stimulation
20. 2+ channel sub-types in peripheral efferent autonomic nerves
21. ω-Conotoxin GVIA-resistant neurotransmitter release in postganglionic sympathetic nerve terminals
22. 2+ channels in neurotransmission in the rat urinary bladder
23. 2+ and tension in isolated rat anococcygeus muscle
24. The effect of omega conotoxin GVIA, a peptide modulator of the N-type voltage sensitive calcium channels, on motor responses produced by activation of efferent and sensory nerves in mammalian smooth muscle
25. Effects of dihydropyridine calcium channel modulators in the heart: Pharmacological and radioligand binding correlation
26. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: A common mechanism of action?
27. Activation of central ATP-sensitive potassium channels produces the antinociception and spinal noradrenaline turnover-enhancing effect in mice